Investigating the Effects of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With IPF: Design of the Randomised Placebo-Controlled INMARK®trial
BMJ Open Respiratory Research - United Kingdom
doi 10.1136/bmjresp-2018-000325
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2018
Authors
Publisher
BMJ